Ads
related to: belimumab lupus nephritis fda approval timeline for vaccines elderly- Dosing & Admin Info
Learn About Dosing & Administration
And Find Helpful Resources & Info.
- BENLYSTA Cares
Talk To Trained Nurses Live To Ask
Questions About The Medication Now.
- Risks And Side Effects
Read The Potential Risks & Common
Side Effects That May Occur.
- About BENLYSTA
Discover More About BENLYSTA
At The Official Site Today.
- BENLYSTA Cares Line
Call Trained Nurses Who Can Answer
Questions About Taking Benlysta.
- Free Tools & Support
Find Injection Training And Support
On The Official Patient Website.
- Dosing & Admin Info
Search results
Results From The WOW.Com Content Network
Belimumab is primarily used in people with systemic lupus erythematosus. When it was introduced in 2011, it was the first new drug approved to treat lupus in 56 years. [8] Sales rose to $31.2 million in the first quarter of 2012. [37] The total cost for the first year of treatment with belimumab is $28,000. [38]
In combination with palbociclib and fulvestrant for the treatment of adults with endocrine-resistant, PIK3CA-mutated, hormone receptor (HR)-positive, human epidermal growth-factor receptor 2 (HER2)-negative, locally advanced or metastatic breast cancer, as detected by an FDA-approved test, following recurrence on or after completing adjuvant ...
2003 – First nasal influenza vaccine approved in U.S. 2003 – First vaccine for Argentine hemorrhagic fever. [16] 2006 – First vaccine for human papillomavirus (which is a cause of cervical cancer) 2006 – First herpes zoster vaccine for shingles; 2011 – First vaccine for non-small-cell lung carcinoma (comprises 85% of lung cancer cases)
For premium support please call: 800-290-4726 more ways to reach us
Fast track is a designation by the United States Food and Drug Administration (FDA) of an investigational drug for expedited review to facilitate development of drugs that treat a serious or life-threatening condition and fill an unmet medical need. Fast track designation must be requested by the drug company.
Prior to approval, each drug marketed in the United States must go through a detailed FDA review process. In 1992, under the Prescription Drug User Fee Act (PDUFA), FDA agreed to specific goals for improving the drug review time and created a two-tiered system of review times – standard review and priority review.
Ads
related to: belimumab lupus nephritis fda approval timeline for vaccines elderly